Lumbar functional evaluation of pelvic bone sarcomas after surgical resection and spinal pelvic fixation: A clinical study of 304 cases.
bone sarcomas
functional outcomes
lumbar functional index
pelvis
spinal pelvic fixation
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
revised:
22
04
2024
received:
27
11
2023
accepted:
30
04
2024
medline:
31
5
2024
pubmed:
31
5
2024
entrez:
31
5
2024
Statut:
ppublish
Résumé
We endeavored to introduce a novel scoring system (Lumbar Functional Index, LFI) capable of evaluating lumbar function in pelvic bone sarcoma patients who underwent surgical resection and spinal pelvic fixation, while simultaneously identifying the incidence, outcomes, and risk factors of lumbar function impairment among these populations. A cohort of 304 primary bone sarcoma patients were recruited. The LFI was created based on the Oswestry Dysfunction Index (ODI) and Japanese Orthopaedic Association (JOA) scores. Lumbar function impairment was defined as LFI score ≥ 18 points, which was identified as high LFI. Demographic data, clinical characteristics, and oncological outcomes were analyzed. The cohort included chondrosarcoma (39.8%), osteosarcoma (29.9%), Ewing sarcoma (8.6%), bone-derived undifferentiated pleomorphic sarcoma (7.2%), giant cell tumor of bone (7.2%), chordoma (2.3%), and other bone sarcomas (5.0%). The LFI score exhibited significant negative correlation with common scoring systems of bone sarcoma. The incidence of high LFI was 23.0%. Patients with high LFI demonstrated a higher prevalence of type I + II + III + IV pelvic tumor, more sacrificed nerve roots and bilateral lumbar spine fixation during surgery, while lower percentage of R0 resection and local control of pelvic tumor. Decreased median overall survival (30 vs. 52 months, p < 0.001) and recurrence-free survival (14 vs. 24 months, p < 0.001) time were observed in these patients. Type I + II + III + IV pelvic tumor and sacrificed nerve roots≥2 were identified as risk factors for high LFI, while R0 resection and local control were identified as protective factors. The LFI scoring system exhibited a significant negative correlation to current scoring systems. High LFI patients had worse prognosis and distinct characteristics. The risk factors of high LFI included type I + II + III + IV pelvic tumor and sacrificed nerve roots≥2, and the protective factors included R0 resection and local control.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e7282Subventions
Organisme : National Natural Science Foundation of China
ID : 82072970
Informations de copyright
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Références
Parry MC, Laitinen M, Albergo J, et al. Osteosarcoma of the pelvis. Bone Joint J. 2016;98‐B(4):555‐563.
Morris CD. Pelvic bone sarcomas: controversies and treatment options. J Natl Compr Cancer Netw. 2010;8(6):731‐737.
Soares do Brito J, Esperanca‐Martins M, Abrunhosa‐Branquinho A, et al. Management of unresectable localized pelvic bone sarcomas: current practice and future perspectives. Cancers (Basel). 2022;14(10):2546.
Lex JR, Kurisunkal V, Kaneuchi Y, et al. Pelvic Ewing sarcoma: should all patients receive pre‐operative radiotherapy, or should it be delivered selectively? Eur J Surg Oncol. 2021;47(10):2618‐2626.
Weinschenk RC, Wang WL, Lewis VO. Chondrosarcoma. J Am Acad Orthop Surg. 2021;29(13):553‐562.
Takenaka S, Araki N, Outani H, et al. Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma. Cancer. 2020;126(18):4188‐4196.
Takemori T, Kawamoto T, Hara H, et al. Clinical outcome of patients with pelvic and retroperitoneal bone and soft tissue sarcoma: a retrospective multicenter study in Japan. Cancers (Basel). 2022;14(12):3023.
Gebert C, Wessling M, Gosheger G, et al. Pelvic reconstruction with compound osteosynthesis following hemipelvectomy: a clinical study. Bone Joint J. 2013;95‐B(10):1410‐1416.
Gallia GL, Suk I, Witham TF, et al. Lumbopelvic reconstruction after combined L5 spondylectomy and total sacrectomy for en bloc resection of a malignant fibrous histiocytoma. Neurosurgery. 2010;67(2):E498‐E502.
Fairbank JC, Pynsent PB. The Oswestry disability index. Spine (Phila Pa 1976). 2000;25(22):2940‐2952.
Goh GS, Soh RCC, Yue WM, Guo CM, Tan SB, Chen JL. Determination of the patient acceptable symptom state for the Japanese Orthopaedic Association Score in patients undergoing anterior cervical discectomy and fusion for cervical spondylotic myelopathy. Spine J. 2020;20(11):1785‐1794.
Fujimori T, Okuda S, Iwasaki M, et al. Validity of the Japanese Orthopaedic Association scoring system based on patient‐reported improvement after posterior lumbar interbody fusion. Spine J. 2016;16(6):728‐736.
van Wulfften Palthe ODR, Janssen SJ, Wunder JS, et al. What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey. Spine J. 2017;17(5):636‐644.
Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996;5(5):508‐516.
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241‐246.
Enneking WF, Dunham WK. Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am. 1978;60(6):731‐746.
Liang H, Guo W, Tang X, et al. Venous tumor thrombus in primary bone sarcomas in the pelvis: a clinical and radiographic study of 451 cases. J Bone Joint Surg Am. 2021;103(16):1510‐1520.
Lazarides AL, Burke ZDC, Gundavda MK, et al. How do the outcomes of radiation‐associated pelvic and sacral bone sarcomas compare to primary osteosarcomas following surgical resection? Cancers (Basel). 2022;14(9):2179.
Fujiwara T, Medellin Rincon MR, Sambri A, et al. Limb‐salvage reconstruction following resection of pelvic bone sarcomas involving the acetabulum. Bone Joint J. 2021;103‐B(4):795‐803.
Hoppe BS, Petersen IA, Wilke BK, et al. Pragmatic, prospective comparative effectiveness trial of carbon ion therapy, surgery, and proton therapy for the management of pelvic sarcomas (soft tissue/bone) involving the bone: the PROSPER study rationale and design. Cancers (Basel). 2023;15(6):1660.
Kadhim M, Womer RB, Dormans JP. Surgical treatment of pelvic sarcoma in children: outcomes for twenty six patients. Int Orthop. 2017;41(10):2149‐2159.
Khan M, Wilkerson H, Vassos N, et al. Oncologic outcomes of surgically managed primary pelvic soft tissue sarcoma; tumour biology or surgical constraints of the true pelvis? Eur J Surg Oncol. 2023;49(5):941‐949.
Ranft A, Seidel C, Hoffmann C, et al. Quality of survivorship in a rare disease: clinicofunctional outcome and physical activity in an observational cohort study of 618 long‐term survivors of Ewing sarcoma. J Clin Oncol. 2017;35(15):1704‐1712.
Kask G, Barner‐Rasmussen I, Repo JP, et al. Functional outcome measurement in patients with lower‐extremity soft tissue sarcoma: a systematic literature review. Ann Surg Oncol. 2019;26(13):4707‐4722.
Deyo RA, Battie M, Beurskens AJ, et al. Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976). 1998;23(18):2003‐2013.
Furlan JC, Catharine CB. Psychometric analysis and critical appraisal of the original, revised, and modified versions of the Japanese Orthopaedic Association Score in the assessment of patients with cervical spondylotic myelopathy. Neurosurg Focus. 2016;40(6):E6.
Lin YY, Liu MF, Tzeng JI, Lin CC. Effects of walking on quality of life among lung cancer patients: a longitudinal study. Cancer Nurs. 2015;38(4):253‐259.
Xiong J, Peng H, Yu Z, et al. Daily walking dose and health‐related quality of life in patients with chronic kidney disease. J Ren Nutr. 2022;32(6):710‐717.
Mosiello G, Gatti C, De Gennaro M, et al. Neurovesical dysfunction in children after treating pelvic neoplasms. BJU Int. 2003;92(3):289‐292.
Sutton EL. Insomnia. Ann Intern Med. 2021;174(3):ITC33‐ITC48.
Perlis ML, Posner D, Riemann D, Bastien CH, Teel J, Thase M. Insomnia. Lancet. 2022;400(10357):1047‐1060.